Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene

This publication has 72 references indexed in Scilit:

• Lupeol inhibits proliferation of human prostate cancer cells by targeting -catenin signaling
  Carcinogenesis: Integrative Cancer Research, 2009
• Suppression of cFLIP by Lupeol, a Dietary Triterpene, Is Sufficient to Overcome Resistance to TRAIL-Mediated Apoptosis in Chemoresistant Human Pancreatic Cancer Cells
  Cancer Research, 2009
• Lupeol, a Dietary Triterpene, Inhibited Growth, and Induced Apoptosis Through Down-Regulation of DR3 in SMMC7721 Cells
  Cancer Investigation, 2009
• Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
  Molecular Cancer Therapeutics, 2008
• Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway
  Biochemical Pharmacology, 2008
• Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
  Nature Reviews Cancer, 2007
• Lupeol and Its Ester Exhibit Protective Role Against Cyclophosphamide-Induced Cardiac Mitochondrial Toxicity
  Journal of Cardiovascular Pharmacology, 2006
• Chemoprevention of cancer
  Carcinogenesis: Integrative Cancer Research, 2000
• Characterization of ursolic acid as a lipoxygenase and cyclooxygenase inhibitor using macrophages, platelets and differentiated HL60 leukemic cells
  FEBS Letters, 1992
• Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro
  Toxicology Letters, 1991